Literature DB >> 23886691

Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.

Chao Gao1, Ting-Hong Ye, Ning-Yu Wang, Xiu-Xiu Zeng, Li-Dan Zhang, Ying Xiong, Xin-Yu You, Yong Xia, Ying Xu, Cui-Ting Peng, Wei-Qiong Zuo, Yuquan Wei, Luo-Ting Yu.   

Abstract

N-Alkyl and heterocycle substituted 1,3-benzothiazin-4-one (BTZ) derivatives were synthesized. The anti-mycobacterial activities of these compounds were evaluated by determination of minimal inhibitory concentration (MIC) for Mycobacterium tuberculosis H37Ra and M. tuberculosis H37Rv. It was found that an extended or branched alkyl chain analog could enhance the potency, and activities of N-alkyl substituted BTZs were not affected by either nitro or trifluoromethyl at 6-position. Trifluoromethyl plays an important role in maintaining anti-tubercular activity in the piperazine or piperidine analogs. Compound 8o, which contains an azaspirodithiolane group, showed a MIC of 0.0001 μM against M. tuberculosis H37Rv, 20-fold more potent than BTZ043 racemate. These results suggested that the volume and lipophilicity of the substituents were important in maintaining activity. In addition, compound 8o was nontoxic to Vero cells and orally bioavailable in a preliminary pharmacokinetics study.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benzothiazinone; DprE1; Structure–activity relationships (SAR); Tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 23886691     DOI: 10.1016/j.bmcl.2013.06.069

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties.

Authors:  Gang Zhang; Michael Howe; Courtney C Aldrich
Journal:  ACS Med Chem Lett       Date:  2019-02-23       Impact factor: 4.345

2.  Design and Syntheses of Anti-Tuberculosis Agents Inspired by BTZ043 Using a Scaffold Simplification Strategy.

Authors:  Rohit Tiwari; Ute Möllmann; Sanghyun Cho; Scott G Franzblau; Patricia A Miller; Marvin J Miller
Journal:  ACS Med Chem Lett       Date:  2014-03-03       Impact factor: 4.345

3.  The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.

Authors:  Vadim Makarov; João Neres; Ruben C Hartkoorn; Olga B Ryabova; Elena Kazakova; Michal Šarkan; Stanislav Huszár; Jérémie Piton; Gaëlle S Kolly; Anthony Vocat; Trent M Conroy; Katarína Mikušová; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

4.  BTZ-Derived Benzisothiazolinones with In Vitro Activity against Mycobacterium tuberculosis.

Authors:  Adrian Richter; Rüdiger W Seidel; Richard Goddard; Tamira Eckhardt; Christoph Lehmann; Julia Dörner; Fabienne Siersleben; Theresia Sondermann; Lea Mann; Michael Patzer; Christian Jäger; Norbert Reiling; Peter Imming
Journal:  ACS Med Chem Lett       Date:  2022-07-25       Impact factor: 4.632

5.  Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.

Authors:  Mark W Majewski; Rohit Tiwari; Patricia A Miller; Sanghyun Cho; Scott G Franzblau; Marvin J Miller
Journal:  Bioorg Med Chem Lett       Date:  2016-02-27       Impact factor: 2.823

6.  Indolyl Azaspiroketal Mannich Bases Are Potent Antimycobacterial Agents with Selective Membrane Permeabilizing Effects and in Vivo Activity.

Authors:  Samuel Agyei Nyantakyi; Ming Li; Pooja Gopal; Matthew Zimmerman; Véronique Dartois; Martin Gengenbacher; Thomas Dick; Mei-Lin Go
Journal:  J Med Chem       Date:  2018-06-25       Impact factor: 7.446

7.  Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis.

Authors:  Chao Gao; Cuiting Peng; Yaojie Shi; Xinyu You; Kai Ran; Lu Xiong; Ting-Hong Ye; Lidan Zhang; Ningyu Wang; Yongxia Zhu; Kun Liu; Weiqiong Zuo; Luoting Yu; Yuquan Wei
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

8.  Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1.

Authors:  Adrian Richter; Ines Rudolph; Ute Möllmann; Kerstin Voigt; Chun-Wa Chung; Onkar M P Singh; Michael Rees; Alfonso Mendoza-Losana; Robert Bates; Lluís Ballell; Sarah Batt; Natacha Veerapen; Klaus Fütterer; Gurdyal Besra; Peter Imming; Argyrides Argyrou
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

9.  8-cyanobenzothiazinone analogs with potent antitubercular activity.

Authors:  Gang Zhang; Li Sheng; Pooja Hegde; Yan Li; Courtney C Aldrich
Journal:  Med Chem Res       Date:  2021-01-13       Impact factor: 1.965

10.  Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis.

Authors:  Adrian Richter; Gagandeep Narula; Ines Rudolph; Rüdiger W Seidel; Christoph Wagner; Yossef Av-Gay; Peter Imming
Journal:  ChemMedChem       Date:  2021-12-23       Impact factor: 3.540

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.